Latent
Latent is an enterprise pharmacy intelligence platform for large health systems, automating prior authorization, specialty fill capture, and medication access.
Latent is the most credentialed bet in enterprise pharmacy intelligence right now — 60+ health systems, a 94.5 KLAS Emerging Company Spotlight score in August 2026, $80M raised, and outcome numbers that are specific rather than directional (2x prior auths per team member, 7 minutes to draft an appeal, $50M in copay assistance secured). It is a platform, not a widget, so budget for native Epic or Cerner integration work and a sales cycle. Pick it when prior auth volume, specialty leakage, and pharmacist burnout are the same problem. Health systems wanting a lightweight prior auth add-on should look at an EHR module instead.
Verified 2d ago · liveness 63/100 · cite: rightaichoice.com/tools/latent
- Pharmacy operations leaders at 500+ bed health systems with high prior auth volume
- Chief pharmacy officers scaling specialty volume without adding headcount
- Prior authorization teams in specialty pharmacy buried in payer paperwork
- Clinical pharmacists who want appeal and reauthorization work off their plate
- Independent pharmacies or small clinics without enterprise pharmacy infrastructure
- Teams looking for a lightweight prior auth point tool rather than a platform rollout
- Consumers seeking direct medication or copay assistance
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Latent if you want a single prior auth widget bolted onto your existing EHR module, or if you lack the IT bandwidth to run a native Epic or Cerner integration project.
As a rule, an enterprise platform rollout with native Epic or Cerner integration sits above the cost of a pharmacy point tool or an EHR-bundled prior auth module, and below what a full custom build or outsourced specialty pharmacy contract would run.
In short
Latent — Latent is an enterprise pharmacy intelligence platform for large health systems, automating prior authorization, specialty fill capture, and medication access. Best for Pharmacy operations leaders at 500+ bed health systems with high prior auth volume, Chief pharmacy officers scaling specialty volume without adding headcount, Prior authorization teams in specialty pharmacy buried in payer paperwork. Contact Sales pricing.
What's new in Latent
Checked 2 days agoAcross the latest 3 updates: 2 feature updates and 1 news mention.
Latent Earns 94.5 in 2026 KLAS Emerging Company Spotlight
KLAS scored Latent Health 94.5 overall in its first Spotlight report on enterprise pharmacy intelligence, with A+ marks for likelihood to recommend and would buy again.
Latent Adds Support for Medicare's GLP-1 Bridge Program
Medicare's GLP-1 Bridge expands eligibility for medicines that previously cost $1,000+/month to roughly $50; Latent outlines how it helps pharmacy teams handle the volume.
Latent Details CIPHER Clinical De-identification Model
CIPHER is a 1.5B-parameter de-identification model reporting 97.9% PHI recall at roughly 1/1000th the inference cost of frontier LLMs and ~50ms per document.
What people actually say about Latent — is it worth it?
We scanned public community sources for Latent on Jul 6, 2026 and could not establish that the discussion we found is about this tool rather than something else sharing its name. Our own analysis of that scan says the posts were off-subject. Rather than publish a sentiment score built on the wrong subject, we publish nothing here and re-run the scan.
Viability Score
How well maintained and how widely used is Latent? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: October 2026
How we score →Key Features
- Clinical agentic engine automating end-to-end medication access workflows
- Automated prior authorization submission, tracking, and status follow-up
- Population scanning to identify patients with medication care gaps
- Payer policy parsing and medical necessity checking
- Appeal drafting cut from 30 minutes of pharmacist time to 7
- Automated reauthorization processing cutting workload roughly 50%
- Real-time specialty fill capture and in-house revenue tracking
- Copay assistance program matching, $50M secured for patients
- Patient engagement with routing to clinical pharmacists
- GLP-1 Bridge support for Medicare's GLP-1 Bridge program (added July 2026)
- CIPHER 1.5B-parameter clinical de-identification model, 97.9% PHI recall
- CIPHER inference at ~50ms per document and ~1/1000th frontier LLM inference cost
- Native EHR integration including Epic and Cerner
- Analytics dashboard for prior auth throughput and specialty capture
- SOC 2 and HIPAA compliant data handling
About Latent
Latent is an enterprise pharmacy intelligence platform built for large health systems, sold as a platform rollout rather than a point tool. Its clinical agentic engine executes medication access work instead of queuing it for staff: payer policy parsing, medical necessity checks, prior authorization submission, appeals, and annual reauthorizations. The vendor's four-stage framing is identify every patient with a care gap, get them access, support compliant treatment, and keep them engaged through the last day of therapy. Published outcomes are concrete rather than directional. Mount Sinai absorbed 15-20% year-over-year prescription volume growth without adding staff. Appeal drafting fell from 30 minutes of pharmacist time to 7. Prior auths per team member roughly doubled with no added headcount. Latent reports 85% specialty fill capture, $300K in annual labor cost avoided, and $50M in copay assistance secured for patients. Two recent additions matter. GLP-1 Bridge, added July 2026, addresses the eligibility surge from Medicare's GLP-1 Bridge program, which cuts medicines that previously ran $1,000+/month to roughly $50. CIPHER, detailed June 2026, is a 1.5B-parameter clinical de-identification model reporting 97.9% PHI recall at roughly 50ms per document and about 1/1000th the inference cost of frontier LLMs, which is what lets a system use its own data without shipping PHI to an outside model. Deployment is native to the EHR, including Epic and Cerner, across 60+ health systems including Mount Sinai, Cleveland Clinic, Mayo Clinic, UCSF Health, Yale New Haven, and Ochsner. Latent raised $80M in March 2026 and scored 94.5 in KLAS's 2026 Emerging Company Spotlight. If you need a single prior auth widget bolted onto your EHR, look at an EHR module instead.
Behind the Verdict
Latent's differentiation is architectural. Most medication access software flags work for a human — it surfaces an authorization that needs filing and lets staff file it. Latent's clinical agentic engine executes the work: parsing payer policy, checking medical necessity, submitting prior authorizations, drafting appeals, and running reauthorizations. That distinction is the only reason the published numbers could be what they are. Appeal drafting at 7 minutes instead of 30 is not an incremental efficiency gain; it changes which appeals are worth filing at all.Strengths: the outcomes are unusually concrete, attributed to named systems (Mount Sinai's 15-20% volume growth absorbed without added staff, Ochsner on time-to-chair for infusion, Yale New Haven on redeploying scarce pharmacist time), and KLAS scored it 94.5 in its 2026 Emerging Company Spotlight with A+ marks for likelihood to recommend and would buy again. The customer list is a genuine signal, not a logo wall — Cleveland Clinic, Mayo Clinic, UCSF Health, AdventHealth, Henry Ford, Cincinnati Children's, and 50-plus others. CIPHER is the most interesting piece technically: a 1.5B-parameter de-identification model reporting 97.9% PHI recall at roughly 50ms per document and about 1/1000th the inference cost of frontier LLMs. That cost profile is what makes running de-identification across an entire patient population practical rather than theoretical, and it keeps PHI inside the system.Weaknesses and caveats: every headline number here is vendor-reported, including the CIPHER recall and cost claims, and none of it has been independently audited. Deployment requires native EHR integration work and internal IT bandwidth; this is not a tool a pharmacy operations lead can switch on. The public site also does not describe developer-facing access, so treat API surface as something to establish during evaluation rather than assume.Where it fits: multi-hospital systems with high specialty prior auth volume, a pharmacy centralization agenda, and specialty fills leaking to outside pharmacies. Where it does not: independent pharmacies, small clinics, teams wanting a point solution, and anyone shopping for themselves rather than for a health system.
Researching Latent? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Latent actually fits — and what changes day-one when you adopt it.
You roll out Latent against your specialty prior auth backlog: the engine scans the population for medication care gaps, files and tracks prior authorizations, and drafts appeals without a pharmacist opening each chart.
Outcome: Prior auths per team member roughly double with no added headcount, appeal drafting drops from 30 minutes to 7, and pharmacist time moves to patient-facing clinical work.
You turn on specialty fill capture and copay assistance matching, then use the analytics dashboard to track fill capture rate and prior auth throughput across sites.
Outcome: Specialty fills stay in-house instead of leaking to outside pharmacies, and $50M-scale copay assistance enrollment gets eligible patients started on therapy they could not otherwise afford.
You run CIPHER over your own clinical data for a de-identification pass before analytics work, keeping PHI inside the system rather than sending records to a frontier model.
Outcome: De-identification runs at roughly 50ms per document with reported 97.9% PHI recall, at about 1/1000th the inference cost of frontier LLMs.
Use Cases
- Automate prior authorizations for specialty medications, cutting patient wait times from weeks to minutes.
- Identify and enroll eligible patients in copay assistance programs to lower out-of-pocket costs.
- Increase specialty fill capture rates by 85% or more by optimizing medication access workflows.
- Run annual reauthorizations in days instead of months using automated processing.
- Free pharmacist time by routing appeals and paperwork to the agentic engine instead of staff.
- Deploy GLP-1 Bridge to manage the eligibility surge under Medicare's low-cost GLP-1 coverage.
- Use CIPHER to de-identify your own clinical data at scale without sending PHI to a frontier model.
- Keep specialty fills in-house rather than letting revenue leak to outside pharmacies.
Models Under the Hood
as of 2026-10-11
Limitations
- The platform is built for enterprise health systems (60+ systems, more than five million patient medication journeys annually) and is sold through direct engagement rather than self-serve signup.
- The public site does not describe developer-facing access or pricing.
- Published outcomes — 2x prior auths per team member, 7 minutes to draft an appeal, $50M in copay assistance secured, $300K in labor cost avoided — are vendor-reported, not independently audited, and CIPHER's 97.9% PHI recall and ~1000x lower inference cost are likewise vendor-reported.
as of 2026-10-09
Verification history
We have re-verified Latent 9 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
Showing the 6 most recent of 9 verification passes.
Free to cite with attribution — this page re-verifies continuously.
Where the pricing makes sense
The company stage and team size where Latent's pricing actually pencils out — and where peers do it cheaper.
As a rule, an enterprise platform rollout with native Epic or Cerner integration sits above the cost of a pharmacy point tool or an EHR-bundled prior auth module, and below what a full custom build or outsourced specialty pharmacy contract would run.
Setup time & first value
How long it actually takes to get something useful out of Latent — broken out by persona, not the marketing-page minute.
Expect an enterprise integration timeline, not a same-week switch-on: Latent deploys natively into Epic or Cerner, so first value depends on your EHR integration project and IT availability. Individual workflows such as appeal drafting show time savings quickly once the engine is live, but budget a multi-week to multi-month rollout scoped with your EHR team.
Switching to or from Latent
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From manual prior auth queues: point Latent's agentic engine at your existing specialty backlog so it files, tracks, and follows up while staff handle exceptions.
- →From an EHR-bundled prior auth module: run Latent alongside it on a subset of specialty drugs to compare appeal turnaround and fill capture before switching volume over.
- →From outsourced specialty pharmacy: bring fills in-house with Latent's specialty fill capture and real-time revenue tracking rather than routing scripts to an external partner.
- ↗To an EHR-bundled prior auth module: if you only ever needed single-drug authorization filing and not platform-level medication access, an Epic or Cerner module covers that narrower scope.
- ↗To outsourced specialty pharmacy: if you decide not to run specialty operations in-house, an external specialty partner takes the fill and prior auth work off your team entirely.
Integrations
Resources & Guides
Tutorials & Learning
YouTube returned 6 videos for “Latent”, and we withheld 6: 6 could not be judged, because “Latent” is a single word that other videos use for other things. We are showing none, because we could not prove any of them are about Latent.
Official links
Featured Head-to-Head Comparisons
Latent vs Codametrix
Pick CodaMetrix if your priority is reducing manual medical coding costs and denials across all service lines in a large health system. Choose Latent if your biggest pain point is pharmacy prior authorization drag and medication access bottlenecks. They serve different departments but are complementary for enterprise health systems.
Latent vs Rapidsos
If you run a 911 center or enterprise safety program, RapidSOS is the clear choice for AI-enhanced dispatch and real-time device data, especially with HARMONY AI now embedded in AT&T ESInet. For health system pharmacy leaders drowning in prior authorizations, Latent's automated workflows and GLP-1 Bridge (July 2026) deliver measurable throughput gains and cost savings. No overlap: pick based on your domain.
Latent vs Isomorphic Labs
Choose Latent if you run a health system pharmacy needing to automate prior auth and medication access workflows — it's plug-and-play with EHRs and proven to increase throughput. Choose Isomorphic Labs if you are a large pharma company wanting a deep R&D partnership for AI-driven drug discovery, leveraging AlphaFold's Nobel-winning science. They serve entirely different markets and are not interchangeable.
Popular in Healthcare Revenue Cycle
CodaMetrix
Autonomous medical coding for large health systems that codes and bills eligible cases touchlessly.
Frequently Asked Questions
Categories
Topics
Used Latent? Help shape our editorial sentiment research.